First-in-class, oral small molecule to prevent weight regain, without need for significant lifestyle modifications — ...

The marketing initiative touts the protein and fiber content of the offerings, which appeals to consumers taking weight-loss ...

The German Diabetes Society (DDG) issued a warning concerning a rise in pregnancies among women using injectable medications ...

Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or doesn't produce enough of it, leading ...

Evidence is mounting that new therapies already used to treat gut diseases, type 2 diabetes, and obesity may help people with alcohol use disorder (AUD).

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

He cited a study that found that although the U.S. has the costliest healthcare system in the world, it ranks 42nd in life ...

It's been a good year for the stock market as a whole and a tremendous year for a couple of drugmaker start-ups. Shares of ...

FTC approves Novo Holdings' $16.5B Catalent acquisition. Deal includes selling 3 facilities to Novo Nordisk for $11B, despite ...

New research shows how weight loss meds like Wegovy are reshaping alcohol habits, offering new insights into addiction ...